https://pharminent.com/week-in-review/week-in-review-intelligence-brief-june-20-2026/ 2026-06-20T21:03:20Z Pharminent en Week in Review • INTELLIGENCE BRIEF • June 20, 2026 2026-06-20T21:03:18Z Blog https://pharminent.com/market-access/market-access-intelligence-weekly-digest-june-19-2026/ 2026-06-20T20:45:25Z Pharminent en MARKET ACCESS INTELLIGENCE • Weekly Digest • June 19, 2026 2026-06-20T20:45:23Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-june-19-2026/ 2026-06-20T20:42:35Z Pharminent en Oncology Intelligence Digest • June 19, 2026 2026-06-20T20:42:33Z Blog https://pharminent.com/82172-2/ 2026-06-19T19:33:41Z Pharminent en 2026-06-19T19:33:38Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-june-19-2026/ 2026-06-19T19:21:12Z Pharminent en GLP-1 Competitive Market Digest • Weekly • June 19, 2026 2026-06-19T19:21:10Z Blog https://pharminent.com/82166-2/ 2026-06-19T18:53:17Z Pharminent en 2026-06-19T18:53:15Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-19-2026/ 2026-06-19T15:57:38Z Pharminent en Strategic News Watch • June 19, 2026 2026-06-19T15:57:36Z Blog https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-june-18-2026/ 2026-06-19T13:25:17Z Pharminent en Rare Disease & Gene Therapy Digest • June 18, 2026 2026-06-19T13:25:15Z Blog https://pharminent.com/biogen-to-acquire-raythera-for-up-to-1bn/ 2026-06-19T15:02:16Z Pharminent en Biogen to acquire RayThera for up to $1bn 2026-06-19T09:23:13Z Blog